"Immunosuppressive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.
| Descriptor ID |
D007166
|
| MeSH Number(s) |
D27.505.696.477.656
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunosuppressive Agents".
Below are MeSH descriptors whose meaning is more specific than "Immunosuppressive Agents".
This graph shows the total number of publications written about "Immunosuppressive Agents" by people in this website by year, and whether "Immunosuppressive Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 3 | 5 |
| 1997 | 2 | 3 | 5 |
| 1998 | 9 | 5 | 14 |
| 1999 | 1 | 0 | 1 |
| 2000 | 5 | 2 | 7 |
| 2001 | 6 | 2 | 8 |
| 2002 | 11 | 5 | 16 |
| 2003 | 2 | 8 | 10 |
| 2004 | 8 | 8 | 16 |
| 2005 | 10 | 6 | 16 |
| 2006 | 5 | 12 | 17 |
| 2007 | 8 | 12 | 20 |
| 2008 | 9 | 21 | 30 |
| 2009 | 7 | 9 | 16 |
| 2010 | 11 | 8 | 19 |
| 2011 | 3 | 3 | 6 |
| 2012 | 9 | 7 | 16 |
| 2013 | 10 | 9 | 19 |
| 2014 | 15 | 8 | 23 |
| 2015 | 13 | 15 | 28 |
| 2016 | 15 | 8 | 23 |
| 2017 | 19 | 11 | 30 |
| 2018 | 8 | 12 | 20 |
| 2019 | 5 | 10 | 15 |
| 2020 | 13 | 10 | 23 |
| 2021 | 11 | 11 | 22 |
| 2022 | 2 | 10 | 12 |
| 2023 | 1 | 9 | 10 |
| 2024 | 4 | 7 | 11 |
| 2025 | 6 | 6 | 12 |
| 2026 | 6 | 5 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunosuppressive Agents" by people in Profiles.
-
Vaccination for Patients With Immunosuppression and Altered Immunity: A Workgroup Report from the AAAAI Adverse Reactions to Drugs, Biologics, and Vaccines Committee and the Autoimmunity and Altered Immune Response Committee. J Allergy Clin Immunol Pract. 2026 07; 14(7):1549-1561.
-
Risk Factors for Acute Rejection in Pediatric Lung Transplantation and Its Impact on Graft Failure. Pediatr Pulmonol. 2026 Mar; 61(3):e71547.
-
Renal Response Outcomes of the EuroLupus and National Institutes of Health Cyclophosphamide Dosing Regimens in Childhood-Onset Proliferative Lupus Nephritis. Arthritis Rheumatol. 2024 Mar; 76(3):469-478.
-
Very-long-chain fatty acids induce glial-derived sphingosine-1-phosphate synthesis, secretion, and neuroinflammation. Cell Metab. 2023 05 02; 35(5):855-874.e5.
-
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease. Respir Res. 2023 Jan 09; 24(1):6.
-
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. Arthritis Rheumatol. 2022 04; 74(4):586-596.
-
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. Arthritis Care Res (Hoboken). 2022 04; 74(4):538-548.
-
Computational validation of ABCB1 gene polymorphism and its effect on tacrolimus dose concentration/levels in renal transplant individuals of South India. Comput Biol Med. 2021 12; 139:104971.
-
COVID-19 in children treated with immunosuppressive medication for kidney diseases. Arch Dis Child. 2021 07 19; 106(8):798-801.
-
Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantation. Br J Haematol. 2021 07; 194(1):145-157.